The key areas of interest for Middlemore Clinical Trials are outlined here to guide enquiries.
Rheumatology Naive and DMAR failure RA,PSA, SLE Gout Gastroenterology HBV, NASH, Inflamatory Bowel Disease (UC & Crohns) Cardiology Stent trials, heart failure, cardiomyopathy Haematology Multiple myeloma, non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, myeloproliferative disorders, CLL, CML, coagulation trials Respiratory Bronchiectasis, COPD, Asthma, Influenza vaccines in adults, RSV vaccines in adults Diabetes T1DM, T2DM, dyslipidaemia, obesity Paediatrics RSV vaccines in mothers and children Radiology Arteriovenous Fistulograms and Angioplasty for dialysis patients, Lower limb arteriograms for peripheral vascular disease, Trials of balloons, cutting balloons, stents, stent grafts, drug coated balloons and stents, atherectomy devices etc. ORL Nasal Stents Dietetics Nutritional Studies
BIO-SIMILAR TRIALS IN NEW ZEALAND New Zealand, due to the government purchasing model has an interest in performing bio-similar trials, particularily in oncology and haematological oncology. This provides clinicians access for their patients to otherwise unavailable medicines. At Middlemore Hospital this is encouraged and supported by the respective departments. To find out more please contact us at email@example.com
Middlemore Hospital departments include:
• Paediatrics led by Dr Adrian Trenholme • Haematology led by Dr Sharon Jackson • Diabetes led by Dr Brandon-Orr Walker • Rheumatology led by Dr Sunil Kumar • Renal medicine led by Dr Christopher Hood • Gastroenterology & Hepatology led by Dr Paul Casey • Cardiology led by Dr Selwyn Wong • Respiratory led by Dr Conroy Wong • Dermatology led by Dr Paul Jarrett • Nutritional Studies led by Alayne Healy • Medicine led Dr Carl Eagleton • ICU led by Dr Alex Kazemi • Orthopedics led by Dr Matthew Tomlinson • Otorhinolaryngology led by Professor Randall Morton • Womans Studies led by Dr Sarah Tout
Middlemore Clinical Trials (MMCT) is New Zealand's largest clinical trials site, which offers world-class facilities, excellent audited procedures, and a fully integrated research unit.